Xykaa BD 1000mg Tablet ER contains Paracetamol 1000mg as its active ingredient and is formulated as an extended-release tablet designed to provide prolonged analgesic and antipyretic effects. Paracetamol, a widely used non-opioid analgesic and antipyretic agent, acts centrally in the brain to inhibit prostaglandin synthesis, thereby reducing pain and fever without significant anti-inflammatory activity. Xykaa BD 1000mg Tablet ER is indicated for the management of mild to moderate pain, including headache, musculoskeletal pain, dental pain, and dysmenorrhea, as well as for the reduction of fever associated with various conditions. The extended-release formulation allows for sustained plasma concentrations, enabling twice-daily dosing, which may improve patient compliance and maintain consistent symptom control. It is generally well-tolerated when used at recommended dosages; however, caution is advised in patients with hepatic impairment or chronic alcohol use due to the risk of hepatotoxicity. Contraindications include known hypersensitivity to paracetamol or any excipients. Patients should avoid concomitant use with other paracetamol-containing products to prevent overdose. Xykaa BD 1000mg Tablet ER should be used under medical supervision, adhering to prescribed dosage to ensure safety and efficacy.